Survival in daily home hemodialysis and matched thrice-weekly in-center hemodialysis patients

Journal of the American Society of Nephrology

Volumn 23, Issue 5, 2012, Pages 895-904

  Weinhandl, Eric D ^a   Liu, Jiannong ^a   Gilbertson, David T ^a   Arneson, Thomas J ^a   Collins, Allan J ^a,b  

^a MINNEAPOLIS MEDICAL RESEARCH FOUNDATION   (United States)

^b UNIVERSITY OF MINNESOTA MEDICAL SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ADULT; ARTICLE; ATHEROSCLEROSIS; BODY MASS; CACHEXIA; CARDIOVASCULAR RISK; CEREBROVASCULAR DISEASE; COMORBIDITY; CONGESTIVE HEART FAILURE; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE DURATION; DISEASE SEVERITY; FEMALE; HEMODIALYSIS PATIENT; HOME DIALYSIS; HUMAN; HYPERTENSION; INFECTION RISK; INTENTION TO TREAT ANALYSIS; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY TRANSPLANTATION; LENGTH OF STAY; MAJOR CLINICAL STUDY; MALE; MEDICAID; MEDICARE; NEOPLASM; PERIPHERAL VASCULAR DISEASE; PRIORITY JOURNAL; SENSITIVITY ANALYSIS; SURVIVAL; TREATMENT WITHDRAWAL;

EID: 84860631591     PISSN: 10466673     EISSN: 15333450     Source Type: Journal    
DOI: 10.1681/ASN.2011080761     Document Type: Article

References (37)

1. US Renal Data System: USRDS 2010 Annual Data Report: Atlas of Chronic Kidney Disease & End-Stage Renal Disease in the United States, Bethesda, MD, National Institutes of Health, National Institute of Diabetes and Digestive and Kidney Diseases, 2010
2. Arneson TJ, Liu J, Qiu Y, Gilbertson DT, Foley RN, Collins AJ: Hospital treatment for fluid overload in the Medicare hemodialysis population. Clin J Am Soc Nephrol 5: 1054-1063, 2010
3. Block GA: Prevalence and clinical consequences of elevated Ca x P product in hemodialysis patients. Clin Nephrol 54: 318-324, 2000
4. Chertow GM, Levin NW, Beck GJ, Depner TA, Eggers PW, Gassman JJ, Gorodetskaya I, Greene T, James S, Larive B, Lindsay RM, Mehta RL, Miller B, Ornt DB, Rajagopalan S, Rastogi A, Rocco MV, Schiller B, Sergeyeva O, Schulman G, Ting GO, Unruh ML, Star RA, Kliger AS FHN Trial Group: In-center hemodialysis six times per week versus three times per week. N Engl J Med 363: 2287-2300, 2010
5. Suri RS, Nesrallah GE, Mainra R, Garg AX, Lindsay RM, Greene T, Daugirdas JT: Daily hemodialysis: A systematic review. Clin J Am Soc Nephrol 1: 33-42, 2006
6. Walsh M, Culleton B, Tonelli M, Manns B: A systematic review of the effect of nocturnal hemodialysis on blood pressure, left ventricular hypertrophy, anemia, mineral metabolism, and health-related quality of life. Kidney Int 67: 1500-1508, 2005 (Pubitemid 40463127)
7. Johansen KL, Zhang R, Huang Y, Chen SC, Blagg CR, Goldfarb- Rumyantzev AS, Hoy CD, Lockridge RS Jr, Miller BW, Eggers PW, Kutner NG: Survival and hospitalization among patients using nocturnal and short daily compared to conventional hemodialysis: A USRDS study. Kidney Int 76: 984-990, 2009
8. Miller BW, Collins AJ, Finkelstein FO, Glickman JD, Hull AR, Kraus MA, McCarthy J, Spry LA, Jaber BL; FREEDOM Group: Daily hemodialysis (DHD) is associated with lower than expected mortality [Abstract]. . J Am Soc Nephrol 20: 192A, 2009
9. Kjellstrand CM, Buoncristiani U, Ting G, Traeger J, Piccoli GB, Sibai- Galland R, Young BA, Blagg CR: Short daily haemodialysis: Survival in 415 patients treated for 1006 patient-years. Nephrol Dial Transplant 23: 3283-3289, 2008
10. Agar JW, Wilson S, Van Eps C, Hawley C, Blagg CR: Comparing the relative survival of an Australian nocturnal home HD cohort with a matched USRDS conventional HD cohort using standardized mortality ratios [Abstract]. J Am Soc Nephrol 18: 513A, 2007
11. Blagg CR, Kjellstrand CM, Ting GO, Young BA: Comparison of survival between short-daily hemodialysis and conventional hemodialysis using the standardized mortality ratio. Hemodial Int 10: 371-374, 2006 (Pubitemid 44489922)
12. Centers for Medicare and Medicaid Services: End Stage Renal Disease Network Organization Program 2009 Summary Annual Report, Baltimore, MD, CMS, 2011
13. Paoletti E, Specchia C, Di Maio G, Bellino D, Damasio B, Cassottana P, Cannella G: The worsening of left ventricular hypertrophy is the strongest predictor of sudden cardiac death in haemodialysis patients: A 10 year survey. Nephrol Dial Transplant 19: 1829-1834, 2004 (Pubitemid 38961395)
14. Stack AG: Determinants of modality selection among incident US dialysis patients: Results from a national study. J Am Soc Nephrol 13: 1279-1287, 2002
15. Devereux RB, Dahlöf B, Gerdts E, Boman K, Nieminen MS, Papademetriou V, Rokkedal J, Harris KE, Edelman JM, Wachtell K: Regression of hypertensive left ventricular hypertrophy by losartan compared with atenolol: The Losartan Intervention for Endpoint Reduction in Hypertension (LIFE) trial. Circulation 110: 1456-1462, 2004 (Pubitemid 39238023)
16. Parfrey PS, Lauve M, Latremouille-Viau D, Lefebvre P: Erythropoietin therapy and left ventricular mass index in CKD and ESRD patients: A meta-analysis. Clin J Am Soc Nephrol 4: 755-762, 2009
17. Besarab A, Bolton WK, Browne JK, Egrie JC, Nissenson AR, Okamoto DM, Schwab SJ, Goodkin DA: The effects of normal as compared with lowhematocrit values in patientswith cardiac diseasewho are receiving hemodialysis and epoetin. N Engl J Med 339: 584-590, 1998 (Pubitemid 28385655)
18. Ioannidis JP, Panagiotou OA: Comparison of effect sizes associated with biomarkers reported in highly cited individual articles and in subsequent meta-analyses. JAMA 305: 2200-2210, 2011
19. Weinhandl ED, Foley RN, Gilbertson DT, Arneson TJ, Snyder JJ, Collins AJ: Propensity-matched mortality comparison of incident hemodialysis and peritoneal dialysis patients. J Am Soc Nephrol 21: 499-506, 2010
20. Saint-Remy A, Krzesinski JM: Optimal blood pressure level and best measurement procedure in hemodialysis patients. Vasc Health Risk Manag 1: 235-244, 2005
21. Kalpakian MA, Mehrotra R: Vascular calcification and disordered mineral metabolism in dialysis patients. Semin Dial 20: 139-143, 2007
22. Kovesdy CP, Regidor DL, Mehrotra R, Jing J, McAllister CJ, Greenland S, Kopple JD, Kalantar-Zadeh K: Serum and dialysate potassium concentrations and survival in hemodialysis patients. Clin J Am Soc Nephrol 2: 999-1007, 2007
23. Mapes DL, Bragg-Gresham JL, Bommer J, Fukuhara S, McKevitt P, Wikström B, Lopes AA: Health-related quality of life in the Dialysis Outcomes and Practice Patterns Study (DOPPS). Am J Kidney Dis 44 [Suppl 2]: 54-60, 2004
24. Jaber BL, Schiller B, Burkart JM, Daoui R, Kraus MA, Lee Y, Miller BW, Teitelbaum I, Williams AW, Finkelstein FO FREEDOM Study Group: Impact of short daily hemodialysis on restless legs symptoms and sleep disturbances. Clin J Am Soc Nephrol 6: 1049-1056, 2011
25. Jaber BL, Lee Y, Collins AJ, Hull AR, Kraus MA, McCarthy J, Miller BW, Spry L, Finkelstein FO FREEDOM Study Group: Effect of daily hemodialysis on depressive symptoms and postdialysis recovery time: Interim report from the FREEDOM (Following Rehabilitation, Economics and Everyday- Dialysis Outcome Measurements) Study. Am J Kidney Dis 56: 531-539, 2010
26. McDade-Montez EA, Christensen AJ, Cvengros JA, Lawton WJ: The role of depression symptoms in dialysis withdrawal. Health Psychol 25: 198-204, 2006
27. Jaber BL, Collins AJ, Finkelstein FO, Glickman JD, Hull AR, Kraus MA, McCarthy J, Miller BW, Spry LA; FREEDOM Study Group: Daily hemodialysis (DHD) reduces the need for anti-hypertensive medications [Abstract]. J Am Soc Nephrol 20: SA-PO2461, 2009
28. Achinger SG, Ayus JC: The role of daily dialysis in the control of hyperphosphatemia. Kidney Int Suppl 95: S28-S32, 2005 (Pubitemid 43361553)
29. Manley HJ, Wang S, Nissenson AR: Medication non-adherence predicts hospitalization rate and healthcare costs in hemodialysis (HD) patients [Abstract]. J Am Soc Nephrol 21: F-PO1207, 2010
30. Shurraw S, Zimmerman D: Vascular access complications in daily dialysis: A systematic review of the literature. Minerva Urol Nefrol 57: 151-163, 2005 (Pubitemid 43942552)
31. Chow J, Rayment G, San Miguel S, Gilbert M: A randomised controlled trial of buttonhole cannulation for the prevention of fistula access complications. J Ren Care 37: 85-93, 2011
32. André MB, Rembold SM, Pereira CM, Lugon JR: Prospective evaluation of an in-center daily hemodialysis program: Results of two years of treatment. Am J Nephrol 22: 473-479, 2002 (Pubitemid 36158506)
33. Pinciaroli AR: Hormonal changes in daily hemodialysis. Semin Dial 12: 455-461, 1999
34. Harwood L, Clark AM: Understanding health decisions using critical realism: Home-dialysis decision-making during chronic kidney disease. Nurs Inq 19: 29-38, 2011
35. Hebert PL, Geiss LS, Tierney EF, Engelgau MM, Yawn BP, McBean AM: Identifying persons with diabetes using Medicare claims data. Am J Med Qual 14: 270-277, 1999
36. Austin PC:Acritical appraisal of propensity-scorematching in themedical literature between 1996 and 2003. Stat Med 27: 2037-2049, 2008
37. Lin DY, Psaty BM, Kronmal RA: Assessing the sensitivity of regression results to unmeasured confounders in observational studies. Biometrics 54: 948-963, 1998 (Pubitemid 28429289)